Clinical Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2005; 11(24): 3724-3728
Published online Jun 28, 2005. doi: 10.3748/wjg.v11.i24.3724
Table 1 COX-2, VEGF, and MVC status in relation to clinicopathological characteristics of patients.
Pathological characteristicsnPositive VEGF (%)Positive COX-2 (%)MVC
Sex
Male2817 (60.7)21 (75.0)56±12
Female3618 (50.0)a25 (69.4)a58±16a
Age (yr)
≥603016 (53.3)22 (73.3)54±13
<603419 (55.9)a24 (70.6)a60±15a
Clinical stage
S1, S2, S32010 (50.0)10 (50.0)49±15
S4, S54425 (56.8)a36 (81.8)b64±12b
Degree of differentiation
Well differentiated217 (33.3)12 (57.1)50±14
Moderately and poorly4328 (65.1)c34 (79.1)a61±13b
differentiated
Lymph node metastasis
Positive4028 (70.0)35 (87.5)65±12
Negative247 (29.2)b11 (45.8)b45±7b